Lung Cancer and Mesothelioma Recommended Treatment is Pemetrexed
Scientists believe that pemetrexed should be the standard treatment choice for unresectable malignant pleural mesothelioma (MPM) and recurrent metastatic non-small cell lung cancer (NSCLC).
This entry was posted on Tuesday, July 11th, 2006 at 4:59 pm and is filed under Non-Small-Cell, Treatment, Mesothelioma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.